CD86 Antikörper
-
- Target Alle CD86 Antikörper anzeigen
- CD86
-
Reaktivität
- Ratte
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD86 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- 24F
- Isotyp
- IgG1
- Top Product
- Discover our top product CD86 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade." in: Journal of virology, Vol. 74, Issue 1, pp. 428-35, (2000) (PubMed).
: "
-
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade." in: Journal of virology, Vol. 74, Issue 1, pp. 428-35, (2000) (PubMed).
-
- Target
- CD86
- Andere Bezeichnung
- CD86 (CD86 Produkte)
- Hintergrund
- Synonyms: B7-2
- Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation
-